Mining biosynthetic gene clusters in Paenibacillus genomes to discover novel antibiotics
BMC Microbiology · 2024
DOI: 10.1186/s12866-024-03375-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Microbiology, 2024. Verfasst von Man Su Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Paenibacillus, Anti-Bacterial Agents, Multigene Family, Genome, Bacterial. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Research Institute of Bioscience and Biotechnology.
Abstract (Originalsprache)
Background
Bacterial antimicrobial resistance poses a severe threat to humanity, necessitating the urgent development of new antibiotics. Recent advances in genome sequencing offer new avenues for antibiotic discovery. Paenibacillus genomes encompass a considerable array of antibiotic biosynthetic gene clusters (BGCs), rendering these species as good candidates for genome-driven novel antibiotic exploration. Nevertheless, BGCs within Paenibacillus genomes have not been extensively studied.
Results
We conducted an analysis of 554 Paenibacillus genome sequences, sourced from the National Center for Biotechnology Information database, with a focused investigation involving 89 of these genomes via antiSMASH. Our analysis unearthed a total of 848 BGCs, of which 716 (84.4%) were classified as unknown. From the initial pool of 554 Paenibacillus strains, we selected 26 available in culture collections for an in-depth evaluation. Genomic scrutiny of these selected strains unveiled 255 BGCs, encoding non-ribosomal peptide synthetases, polyketide synthases, and bacteriocins, with 221 (86.7%) classified as unknown. Among these strains, 20 exhibited antimicrobial activity against the gram-positive bacterium Micrococcus luteus , yet only six strains displayed activity against the gram-negative bacterium Escherichia coli . We proceeded to focus on Paenibacillus brasilensis , which featured five new BGCs for further investigation. To facilitate detailed characterization, we constructed a mutant in which a single BGC encoding a novel antibiotic was activated while simultaneously inactivating multiple BGCs using a cytosine base editor (CBE). The novel antibiotic was found to be localized to the cell wall and demonstrated activity against both gram-positive bacteria and fungi. The chemical structure of the new antibiotic was elucidated on the basis of ESIMS, 1D and 2D NMR spectroscopic data. The novel compound, with a molecular weight of 926, was named bracidin.
Conclusions
This study outcome highlights the potential of Paenibacillus species as valuable sources for novel antibiotics. In addition, CBE-mediated dereplication of antibiotics proved to be a rapid and efficient method for characterizing novel antibiotics from Paenibacillus species, suggesting that it will greatly accelerate the genome-based development of new antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
- Department of Biosystems and Bioengineering, KRIBB School of Biotechnology, University of Science and Technology (UST), Daejeon, Republic of Korea.
- Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of Korea.
- Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of Korea. jangjh@kribb.re.kr.
- Department of Applied Biological Engineering, KRIBB School of Biotechnology, University of Science and Technology (UST), Daejeon, Republic of Korea. jangjh@kribb.re.kr.
- Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea. sookeun@kribb.re.kr.
Förderung
- National Research Foundation of Korea
- Korea Research Institute of Bioscience and Biotechnology
Zitieren
APA
Kim, M. S., Jeong, D. E., Jang, J. P., Jang, J. H., & Choi, S. K. (2024). Mining biosynthetic gene clusters in Paenibacillus genomes to discover novel antibiotics. BMC Microbiology. https://doi.org/10.1186/s12866-024-03375-5
Vancouver
Kim MS, Jeong DE, Jang JP, Jang JH, Choi SK. Mining biosynthetic gene clusters in Paenibacillus genomes to discover novel antibiotics. BMC Microbiology. 2024. doi:10.1186/s12866-024-03375-5
BibTeX
@article{Kim2024,
author = {Kim, Man Su and Jeong, Da-Eun and Jang, Jun-Pil and Jang, Jae-Hyuk and Choi, Soo-Keun},
title = {Mining biosynthetic gene clusters in Paenibacillus genomes to discover novel antibiotics},
journal = {BMC Microbiology},
year = {2024},
doi = {10.1186/s12866-024-03375-5}
}
EUVIMED